NON-ANTIBODY IMMUNOTHERAPY OF CANCER

被引：22

作者：

CHAPMAN, PB

HOUGHTON, AN

机构：

[1] Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021

来源：

CURRENT OPINION IN IMMUNOLOGY | 1993年 / 5卷 / 05期

关键词：

D O I：

10.1016/0952-7915(93)90128-F

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Immunotherapeutic agents have become important additions to the list of anti-cancer treatments; further progress will require more information about how the immune system can respond to tumor cells. Tumor cells can avoid eliciting an immune response through several mechanisms. Understanding these mechanisms may Suggest strategies to manipulate tumor cells so that they trigger an effective immune response. Another strategy being developed is to improve the therapeutic index of cytokines so that better anti-tumor effects can be elicited with less toxicity.

引用

收藏

页码：726 / 731

页数：6

相关论文

共 33 条

[1] EXPRESSION OF MURINE INTERLEUKIN-7 IN A MURINE GLIOMA CELL-LINE RESULTS IN REDUCED TUMORIGENICITY INVIVO [J].

AOKI, T ;

TASHIRO, K ;

MIYATAKE, S ;

KINASHI, T ;

NAKANO, T ;

ODA, Y ;

KIKUCHI, H ;

HONJO, T .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3850-3854

[2] ALTERED BINDING OF REGULATORY FACTORS TO HLA CLASS-I ENHANCER SEQUENCE IN HUMAN TUMOR-CELL LINES LACKING CLASS-I ANTIGEN EXPRESSION [J].

BLANCHET, O ;

BOURGE, JF ;

ZINSZNER, H ;

ISRAEL, A ;

KOURILSKY, P ;

DAUSSET, J ;

DEGOS, L ;

PAUL, P .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) :3488-3492

[3] EFFECTS OF LOCAL BACILLUS CALMETTE-GUERIN THERAPY IN PATIENTS WITH BLADDER-CARCINOMA ON IMMUNOCOMPETENT CELLS OF THE BLADDER WALL [J].

BOHLE, A ;

GERDES, J ;

ULMER, AJ ;

HOFSTETTER, AG ;

FLAD, HD .

JOURNAL OF UROLOGY, 1990, 144 (01) :53-58

[4] SELECTIVE MODULATION OF HUMAN NATURAL-KILLER-CELLS INVIVO AFTER PROLONGED INFUSION OF LOW-DOSE RECOMBINANT INTERLEUKIN-2 [J].

CALIGIURI, MA ;

MURRAY, C ;

ROBERTSON, MJ ;

WANG, E ;

COCHRAN, K ;

CAMERON, C ;

SCHOW, P ;

ROSS, ME ;

KLUMPP, TR ;

SOIFFER, RJ ;

SMITH, KA ;

RITZ, J .

JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :123-132

[5] COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].

CHEN, LP ;

ASHE, S ;

BRADY, WA ;

HELLSTROM, I ;

HELLSTROM, KE ;

LEDBETTER, JA ;

MCGOWAN, P ;

LINSLEY, PS .

CELL, 1992, 71 (07) :1093-1102

[6]

COLOMBO MP, 1992, CANCER RES, V52, P4853

[7] REGRESSION OF BLADDER-TUMORS IN MICE TREATED WITH INTERLEUKIN-2 GENE-MODIFIED TUMOR-CELLS [J].

CONNOR, J ;

BANNERJI, R ;

SAITO, S ;

HESTON, W ;

FAIR, W ;

GILBOA, E .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :1127-1134

[8] VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].

DRANOFF, G ;

JAFFEE, E ;

LAZENBY, A ;

GOLUMBEK, P ;

LEVITSKY, H ;

BROSE, K ;

JACKSON, V ;

HAMADA, H ;

PARDOLL, D ;

MULLIGAN, RC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543

[9] PENTOXIFYLLINE INHIBITS INTERLEUKIN-2-INDUCED TOXICITY IN C57BL/6 MICE BUT PRESERVES ANTITUMOR EFFICACY [J].

EDWARDS, MJ ;

HENIFORD, BT ;

KLAR, EA ;

DOAK, KW ;

MILLER, FN .

JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) :637-641

[10]

FRANKSSON I, 1993, J EXP MED, V177, P201

← 1 2 3 4 →